Dipna Pharmachem Limited is one the leading India-based pharmaceutical companies. It is engaged in the business of trading, exporting, and importing industrial chemical and pharmaceutical raw materials, such as APIs, excipients, and solvents. The company was incorporated on 19 July 2011 as a non-government Private Limited company. Its headquarters is in Makarba, Ahmedabad, and its market capitalisation, as of 28 October 2022, is Rs 25.08 crore.
The company floated its IPO on 25 August 2022 to raise funding through the sale of its equity ownership. The company got listed on the Bombay Stock Exchange’s SME Platform (BSE SME) on 7 September 2022. The scrip code of the company for BSE is 543594.
The company is known for its quality, innovation, and exceptional services, among its clients since its existence in the industry. It provides import and export services to its clients in India and abroad. The company has also received several global-benchmark certificates, such as WHO-GMP. The company has reported consolidated sales of Rs 72.76 crore for the financial year 2021-2022, with an operating profit of Rs 2.25 crore.
The current shareholding pattern of the company reflects a 66.56% stake in the company is held by promoters, a 29.55% stake is held by Indian public investors, and the remaining 3.89% stake is held by other domestic investors. The company’s management team comprises Mr Keyur Dipakkumar Shah (managing director), Mrs Dipna Keyur Shah (non-executive director), Mr Chinu Kalal (independent director), and Mr Nandish Shaileshbhai Jani (independent director), among others.
On 28 October 2022, Dipna Pharmachem Limited’s share price at the BSE was Rs 20.65 per share after the market closing. The 52-week high price of this share is Rs 33.60, and the 52-week low price is Rs 19.45. The PE ratio and PB ratio of the company, as of 28 October 2022, are 21.29 and 0.93, respectively. Dipna Pharmachem Limited’s shares have given a return of -15.20% since its inception. The top peers of the company include Aegis Logistics, Rain Industries, Adani Enterprises, and Redington.
Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code: 07730), BSE Ltd (Member Code: 103) and Member of Multi Commodity Exchange of India Ltd.(Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701022, E-mail address: complianceofficer@icicisecurities.com. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.
Dipna Pharmachem share price as on 02 Mar 2026 is Rs. 7.99. Over the past 6 months, the Dipna Pharmachem share price has decreased by 57.84% and in the last one year, it has decreased by 35.51%. The 52-week low for Dipna Pharmachem share price was Rs. 7.98 and 52-week high was Rs. 26.31.
Dipna Pharmachem Limited is one the leading India-based pharmaceutical companies. It is engaged in the business of trading, exporting, and importing industrial chemical and pharmaceutical raw materials, such as APIs, excipients, and solvents. The company was incorporated on 19 July 2011 as a non-government Private Limited company. Its headquarters is in Makarba, Ahmedabad, and its market capitalisation, as of 28 October 2022, is Rs 25.08 crore.
The company floated its IPO on 25 August 2022 to raise funding through the sale of its equity ownership. The company got listed on the Bombay Stock Exchange’s SME Platform (BSE SME) on 7 September 2022. The scrip code of the company for BSE is 543594.
The company is known for its quality, innovation, and exceptional services, among its clients since its existence in the industry. It provides import and export services to its clients in India and abroad. The company has also received several global-benchmark certificates, such as WHO-GMP. The company has reported consolidated sales of Rs 72.76 crore for the financial year 2021-2022, with an operating profit of Rs 2.25 crore.
The current shareholding pattern of the company reflects a 66.56% stake in the company is held by promoters, a 29.55% stake is held by Indian public investors, and the remaining 3.89% stake is held by other domestic investors. The company’s management team comprises Mr Keyur Dipakkumar Shah (managing director), Mrs Dipna Keyur Shah (non-executive director), Mr Chinu Kalal (independent director), and Mr Nandish Shaileshbhai Jani (independent director), among others.
On 28 October 2022, Dipna Pharmachem Limited’s share price at the BSE was Rs 20.65 per share after the market closing. The 52-week high price of this share is Rs 33.60, and the 52-week low price is Rs 19.45. The PE ratio and PB ratio of the company, as of 28 October 2022, are 21.29 and 0.93, respectively. Dipna Pharmachem Limited’s shares have given a return of -15.20% since its inception. The top peers of the company include Aegis Logistics, Rain Industries, Adani Enterprises, and Redington.
Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code: 07730), BSE Ltd (Member Code: 103) and Member of Multi Commodity Exchange of India Ltd.(Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701022, E-mail address: complianceofficer@icicisecurities.com. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.
Dipna Pharmachem share price as on 02 Mar 2026 is Rs. 7.99. Over the past 6 months, the Dipna Pharmachem share price has decreased by 57.84% and in the last one year, it has decreased by 35.51%. The 52-week low for Dipna Pharmachem share price was Rs. 7.98 and 52-week high was Rs. 26.31.
